Specific promoter methylation identifies different subgroups of MLL-rearranged infant acute lymphoblastic leukemia, influences clinical outcome, and provides therapeutic options.
暂无分享，去创建一个
R. Stam | R. Pieters | M. Valsecchi | J. Boer | R. D. de Menezes | Eddy H J van Roon | P. de Lorenzo | P. Schneider | D. Stumpel | R. D. De Menezes | E. V. van Roon